Insights from 2023 ASCO® Annual Meeting
M

ASCO® 2023 Insights: "Phase 3 INDIGO Study Updates - Vorasidenib vs. Placebo for Residual or Recurrent Grade 2 Glioma With an IDH1/2 Mutation"

By Insights from 2023 ASCO® Annual Meeting FEATURING Matthias Preusser
By Insights from 2023 ASCO® Annual Meeting FEATURING Matthias Preusser
298 views
June 15, 2023
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
16:02
Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

cfDNA for Liquid Biopsy for Patients With Glioblastoma

Feat. S. Bagley
22:28
Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

RANO 2.0 and Advances in Neuroimaging: Impact on Clinical Trials and…

Feat. S. Mohan
27:27
Dana-Farber Cancer Institute

Updates on Glioblastoma

Feat. D. Reardon
17:33
Henry Friedman

Overview and Updates in Brain Tumors

13:23
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "A Pooled Analysis of T-DXd for HER2+ mBC Wi…

Feat. S. Hurvitz
13:47
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Expanding the Benefit - Dabrafenib/Tramet…

Feat. V. Subbiah
12:51
Matthias Preusser

Treatment Approaches to Glioblastoma

22:52
Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

Seizure Management for Brain Tumor Survivors: Current Concepts

Feat. S. Sinha
21:55
Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

Overcoming Barriers to Extend Survival: Promising Results of Clinica…

Feat. S. Brem
08:21
Total Health

Systemic Therapy for HER2+ CNS Disease: Management of Breast Cancer …

Feat. C. Santa-Maria
12:26
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2024

2024 Neuro-Oncology Update: NSCLC and Brain Mets

Feat. T. McGranahan
04:42
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2024

2024 Neuro-Oncology Update: Breast Cancer and Brain Mets

Feat. T. McGranahan
20:09
Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

Medical and Symptom Management of Patients With Brain Tumors

Feat. A. Pruitt
05:41
ESMO 2022 Conference Coverage

ESMO 2022 on the DAISY Trial: Antitumor Activity of T-DXd in Patient…

Feat. N. Epaillard
10:27
Robert McBane

2023 ISTH Insights: "The EVE Trial - Extending VTE Secondary Pr…

07:34
Marcelo Negrao

Intracranial Efficacy of Adagrasib in Patients From the KRYSTAL-1 Tr…

18:14
Janakiraman Subramanian

Understanding KRAS G12C Positive Lung Cancer

17:18
Insights from 2023 SABCS

SABCS 2023 Insights: "ELECTRA Study of Elacestrant in Combinati…

Feat. N. Ibrahim
08:51
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2024

2024 Neuro-Oncology Update: Brain Tumors

Feat. T. McGranahan
18:14
ILCC 2022 Conference Coverage

Systemic Therapy for Brain Metastases in NSCLC

Feat. E. Massarelli